We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty

This study has been withdrawn prior to enrollment.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00585988
First Posted: January 4, 2008
Last Update Posted: June 21, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Zimmer Biomet ( Biomet Orthopedics, LLC )
December 21, 2007
January 4, 2008
June 21, 2017
June 2007
September 2009   (Final data collection date for primary outcome measure)
Functional Tests [ Time Frame: 1 year ]
Same as current
Complete list of historical versions of study NCT00585988 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty
Functional Recovery Following Hip Resurfacing or Total Hip Arthroplasty in Patients Matched By Age, Gender, and Activity Level
The primary purpose of this study is to compare early functional outcomes in patients undergoing hip resurfacing and total hip arthroplasty with the M2a-Magnum™ using more objective measures of function.
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
  • Osteoarthritis
  • Rheumatoid Arthritis
  • Arthritis
  • Traumatic Arthritis
  • Device: Hip Resurfacing System
    This arm will utilize a hip resurfacing system.
  • Device: M2a-Magnum™ Large Metal Articulation
    This arm will utilize the M2a-Magnum™ implant system.
  • 1
    Intervention: Device: Hip Resurfacing System
  • 2
    Intervention: Device: M2a-Magnum™ Large Metal Articulation
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
September 2010
September 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients requiring hip arthroplasty

Exclusion Criteria:

  • Patients with sensory, neurological, or general health conditions that alter perception of their limb in space
  • Patients with vestibular disorders
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
 
NCT00585988
292-U-010
No
Not Provided
Not Provided
Zimmer Biomet ( Biomet Orthopedics, LLC )
Biomet Orthopedics, LLC
Not Provided
Not Provided
Zimmer Biomet
June 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP